WinstonWınston
VIDA Global logo

VIDA Global

VIDA
23
Software - Application · Technology
Price
$2.32
-0.05 (-2.11%)
Market Cap
$46.4M
Winston Score
23
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+4828.5% over 2y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 290K (2023) → 14.3M (2025)

VIDA Global Inc. is a small technology company that uses artificial intelligence to analyze medical images, particularly chest X-rays and CT scans. Its software helps doctors and hospitals detect diseases like lung cancer and chronic obstructive pulmonary disease (COPD) more quickly. The company sells its tools to healthcare providers, research institutions, and pharmaceutical companies running clinical trials.

VIDA makes money by licensing its AI software platform to customers, primarily in the United States. With a market cap of around $100 million, it is a very small player in the medical imaging software space, competing against much larger companies with deeper resources. The company is currently losing a significant amount of money relative to its revenue, as shown by its deeply negative operating margin, and its main challenge is scaling up sales fast enough to reach profitability before it runs out of runway.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+14.8% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-101.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (15%)

Research and development spending

Insider Activity

75.9%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

5+ years

Quarterly Free Cash Flow

→ Burn rate stable

$67,911 cash & investments at current burn rate

Growth context

VIDA Global is growing revenue at 15% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
61.0%
Premium pricing power — 61.0% gross margin
Operating Margin
-45.9%
Losing money on operations — -45.9%
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+1.0%
Nearly flat sales (1.0% YoY)
EPS YoY
-91.2%
Earnings shrinking (-91.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
-22%
Weak — only -22% of profit becomes cash
FCF Margin
-0.8%
Burning cash (-0.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial